Sleepiz raises million 6,2 Swiss francs in Series A financing round
Touching lives without touching
ZÜRICH, March 7, 2022 - Medtech startup Sleepiz has successfully completed a second closing of its Series A financing round. The company was able to raise an additional CHF 1.8 million, bringing the total investment to CHF 6.2 million. The fresh capital will primarily be used to launch the sleep apnea monitor in foreign markets.
Zurich-based medtech startup Sleepiz has raised a further CHF 1.8 million in a second closing. This brings the total volume for Series A to CHF 6.2 million. The main investors in the first closing included Verve Ventures, ZKB, a U.S. health insurance company and the four judges of "Höhle der Löwen Schweiz." "We will use the newly raised capital to further roll out our monitor for the diagnosis of sleep disorders," says Max Sieghold, co-founder of Sleepiz. "The launch in Germany is planned for the coming weeks. Other countries will follow."
Revolutionary way of sleep monitoring
ETH spinoff Sleepiz has developed the first contactless monitor, approved as a medical device in Europe, to measure breathing rate and diagnose sleep disorders such as sleep apnea. People suffering from poor sleep need only request it online or have it prescribed by their doctor and place it next to their bed for three nights. The device then monitors nighttime breathing with 99 percent accuracy - without any wiring. The data generated is simultaneously transmitted to a cloud platform and analyzed in the form of reports and trend analyses so that it can be discussed with an expert. Sleepiz is an extremely cost-effective and convenient alternative to the sleep lab and accordingly has the potential to revolutionize the market.
Sleepiz AG (Ltd.) was founded in 2018 as a spin-off from ETH Zurich by Marc Rullan, Max Sieghold and Soumya Sunder Dash and aims to improve people's lives by helping to shape the future of healthcare. With its eponymous device, the medtech startup has developed a convenient and cost-effective way to screen for sleep and diagnose sleep disorders such as sleep apnea. Sleepiz has been a partner of the Lunge Zurich association since the summer of 2021. The startup, which has over 50 employees, has raised over CHF 6.2 million in investment capital to date and has received funding from institutions such as Innosuisse (Swiss Innovation Agency) and the European Commission. Investors include ZKB, Verve Ventures, an American health insurance company and the four jurors of "Die Höhle der Löwen Schweiz". More info at apnoe-screening.ch and Sleepiz.com.